Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $29,875 |
Sells | 34 | $1,008,056 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
11 Sep 2024 16:01 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 09 Sep 2024 | Sale | 2,642 | 0.6577 | 1,738 | D |
11 Mar 2024 17:20 | XFOR | X4 Pharmaceuticals Inc | TAVERAS ARTHUR | Chief Scientific Officer | 11 Mar 2024 | Sale | 14,235 | 0.8818 | 12,552 | D |
11 Mar 2024 17:20 | XFOR | X4 Pharmaceuticals Inc | RAGAN PAULA | President and CEO | 11 Mar 2024 | Sale | 49,678 | 0.8828 | 43,856 | D |
11 Mar 2024 17:19 | XFOR | X4 Pharmaceuticals Inc | MOSTAFA ADAM S. | Chief Financial Officer | 11 Mar 2024 | Sale | 52,500 | 0.8828 | 46,347 | D |
11 Mar 2024 17:19 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 11 Mar 2024 | Sale | 15,409 | 0.882 | 13,591 | D |
12 Feb 2024 17:23 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 12 Feb 2024 | Sale | 3,683 | 1.007 | 3,709 | D |
12 Feb 2024 17:23 | XFOR | X4 Pharmaceuticals Inc | TAVERAS ARTHUR | Chief Scientific Officer | 12 Feb 2024 | Sale | 787 | 1.0072 | 793 | D |
12 Feb 2024 17:05 | XFOR | X4 Pharmaceuticals Inc | RAGAN PAULA | President and CEO | 12 Feb 2024 | Sale | 21,695 | 1.0091 | 21,892 | D |
12 Feb 2024 17:03 | XFOR | X4 Pharmaceuticals Inc | MOSTAFA ADAM S. | Chief Financial Officer | 12 Feb 2024 | Sale | 27,721 | 1.0091 | 27,973 | D |
03 Nov 2023 17:26 | XFOR | X4 Pharmaceuticals Inc | RAGAN PAULA | President and CEO | 01 Nov 2023 | Sale | 199,531 | 0.73 | 145,658 | D |
03 Nov 2023 17:26 | XFOR | X4 Pharmaceuticals Inc | RAGAN PAULA | President and CEO | 03 Nov 2023 | Sale | 39,906 | 0.9 | 35,915 | D |
03 Nov 2023 16:42 | XFOR | X4 Pharmaceuticals Inc | MOSTAFA ADAM S. | Chief Financial Officer | 01 Nov 2023 | Sale | 230,645 | 0.73 | 168,371 | D |
03 Nov 2023 16:40 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 01 Nov 2023 | Sale | 67,695 | 0.73 | 49,417 | D |
03 Nov 2023 16:39 | XFOR | X4 Pharmaceuticals Inc | BALDRY MARK | Chief Commercial Officer | 01 Nov 2023 | Sale | 10,257 | 0.73 | 7,488 | D |
03 Nov 2023 16:39 | XFOR | X4 Pharmaceuticals Inc | TAVERAS ARTHUR | Chief Scientific Officer | 01 Nov 2023 | Sale | 67,695 | 0.73 | 49,417 | D |
12 Sep 2023 16:04 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 08 Sep 2023 | Sale | 2,642 | 1.249 | 3,300 | D |
22 Aug 2023 16:09 | XFOR | X4 Pharmaceuticals Inc | WYZGA MICHAEL S | Director | 18 Aug 2023 | Purchase | 25,000 | 1.195 | 29,875 | D |
11 Aug 2023 19:26 | XFOR | X4 Pharmaceuticals Inc | STEWART MURRAY | Interim Chief Medical Officer | 10 Aug 2023 | Sale | 130,056 | 1.06 | 137,859 | D |
05 Jul 2023 16:05 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 30 Jun 2023 | Sale | 464 | 1.89 | 877 | D |
05 Jul 2023 16:04 | XFOR | X4 Pharmaceuticals Inc | MOSTAFA ADAM S. | Chief Financial Officer | 30 Jun 2023 | Sale | 2,641 | 1.89 | 4,991 | D |
26 Jun 2023 16:15 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 23 Jun 2023 | Sale | 857 | 1.93 | 1,654 | D |
26 Jun 2023 16:13 | XFOR | X4 Pharmaceuticals Inc | MOSTAFA ADAM S. | Chief Financial Officer | 23 Jun 2023 | Sale | 5,417 | 1.93 | 10,455 | D |
26 Jun 2023 16:11 | XFOR | X4 Pharmaceuticals Inc | RAGAN PAULA | President and CEO | 23 Jun 2023 | Sale | 6,724 | 1.92 | 12,910 | D |
16 Jun 2023 16:24 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 15 Jun 2023 | Sale | 857 | 2.23 | 1,911 | D |
16 Jun 2023 16:17 | XFOR | X4 Pharmaceuticals Inc | MOSTAFA ADAM S. | Chief Financial Officer | 15 Jun 2023 | Sale | 5,417 | 2.22 | 12,026 | D |
16 Jun 2023 16:15 | XFOR | X4 Pharmaceuticals Inc | RAGAN PAULA | President and CEO | 15 Jun 2023 | Sale | 6,724 | 2.23 | 14,995 | D |
31 May 2023 17:05 | XFOR | X4 Pharmaceuticals Inc | RAGAN PAULA | President and CEO | 31 May 2023 | Sale | 6,292 | 1.95 | 12,269 | D |
13 Mar 2023 16:52 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 10 Mar 2023 | Sale | 18,192 | 0.84 | 15,281 | D |
13 Mar 2023 16:50 | XFOR | X4 Pharmaceuticals Inc | MOSTAFA ADAM S. | Chief Financial Officer | 10 Mar 2023 | Sale | 52,500 | 0.84 | 44,100 | D |
13 Mar 2023 16:48 | XFOR | X4 Pharmaceuticals Inc | TAVERAS ARTHUR | Chief Scientific Officer | 10 Mar 2023 | Sale | 16,806 | 0.84 | 14,117 | D |
13 Mar 2023 16:46 | XFOR | X4 Pharmaceuticals Inc | RAGAN PAULA | President and CEO | 10 Mar 2023 | Sale | 49,678 | 0.84 | 41,730 | D |
15 Feb 2023 17:13 | XFOR | X4 Pharmaceuticals Inc | TAVERAS ARTHUR | Chief Scientific Officer | 13 Feb 2023 | Sale | 928 | 0.93 | 863 | D |
15 Feb 2023 17:13 | XFOR | X4 Pharmaceuticals Inc | DIBIASE MARY | Chief Operating Officer | 13 Feb 2023 | Sale | 4,348 | 0.93 | 4,044 | D |
15 Feb 2023 17:12 | XFOR | X4 Pharmaceuticals Inc | MOSTAFA ADAM S. | Chief Financial Officer | 13 Feb 2023 | Sale | 27,721 | 0.93 | 25,781 | D |
15 Feb 2023 17:11 | XFOR | X4 Pharmaceuticals Inc | RAGAN PAULA | President and CEO | 13 Feb 2023 | Sale | 21,695 | 0.93 | 20,176 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)